Researchers at the University of Buffalo’s Institute for Lasers, Photonics and Biophotonics are working towards developing imaging systems using nanoparticle-based imaging technology. Using nanobiotechnology, the scientists are designing these nanoparticle systems to contain multiple-contrast agents for multiple varieties of medical-imaging approaches. The end-goal is to find ways to discover cancerous tissue and other problems very early with systems that provide comprehensive data to clinicians, according to The University of Buffalo Reporter.
“We are aiming to provide them with such data by developing nanoparticle platforms capable of carrying multiple-contrast agents for complementary medical-imaging techniques in the same nano-sized package,” said Paras Prasad, executive director of the Institute for Lasers, Photonics and Biophotonics and SUNY Distinguished Professor in the Department of Chemistry, College of Arts and Sciences.
The nanoprobes will have uses with the following applications: optical imaging techniques, especially those that use fluorescence and raman scattering; MRI; PET; CT; and SPECT.